Which has preferable earnings & valuation, AIMDW or HUMAW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ainos $18.11K N/A N/A N/A N/A Humacyte $2.02M N/A N/A N/A N/A

Is AIMDW or HUMAW more profitable?

Company Net Margins Return on Equity Return on Assets Ainos N/A N/A N/A Humacyte N/A N/A N/A

Which has preferable earnings and valuation, HUMAW or ALVOW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Humacyte $2.02M N/A N/A N/A N/A Alvotech $586.32M N/A N/A N/A N/A

Is HUMAW or ALVOW more profitable?

Company Net Margins Return on Equity Return on Assets Humacyte N/A N/A N/A Alvotech N/A N/A N/A

Which has better earnings & valuation, HUMAW or ARAV?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Humacyte $2.02M N/A N/A N/A N/A Aravive N/A N/A N/A -$0.90 N/A

Is HUMAW or ARAV more profitable?

Company Net Margins Return on Equity Return on Assets Humacyte N/A N/A N/A Aravive N/A N/A N/A

Which has preferable valuation and earnings, HUMAW or ACABW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Humacyte $2.02M N/A N/A N/A N/A Atlantic Coastal Acquisition Corp. II N/A N/A N/A N/A N/A

Is HUMAW or ACABW more profitable?

Company Net Margins Return on Equity Return on Assets Humacyte N/A N/A N/A Atlantic Coastal Acquisition Corp. II N/A N/A N/A

Which has better valuation & earnings, HUMAW or BFRIW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Humacyte $2.02M N/A N/A N/A N/A Biofrontera $43.20M N/A N/A N/A N/A

Is HUMAW or BFRIW more profitable?

Company Net Margins Return on Equity Return on Assets Humacyte N/A N/A N/A Biofrontera N/A N/A N/A

Humacyte (HUMAW) Competitors

$0.05 +0.00 (+1.67%)

As of 06/8/2026 03:40 PM Eastern

Compare

HUMAW vs. AIMDW, ALVOW, ARAV, ACABW, and BFRIW

Should you buy Humacyte stock or one of its competitors? MarketBeat compares Humacyte with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Humacyte include Ainos (AIMDW), Alvotech (ALVOW), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), and Biofrontera (BFRIW). These companies are all part of the "pharmaceutical products" industry.

How does Humacyte compare to Ainos?

Ainos (NASDAQ:AIMDW) and Humacyte (NASDAQ:HUMAW) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, risk, analyst recommendations, profitability, media sentiment, dividends, earnings and valuation.

Company	Net Margins	Return on Equity	Return on Assets
Ainos	N/A	N/A	N/A
Humacyte	N/A	N/A	N/A

In the previous week, Ainos had 1 more articles in the media than Humacyte. MarketBeat recorded 1 mentions for Ainos and 0 mentions for Humacyte. Ainos' average media sentiment score of 0.49 beat Humacyte's score of 0.00 indicating that Ainos is being referred to more favorably in the media.

Company	Overall Sentiment
Ainos	Neutral
Humacyte	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ainos	$18.11K	N/A	N/A	N/A	N/A
Humacyte	$2.02M	N/A	N/A	N/A	N/A

Summary

Ainos beats Humacyte on 2 of the 3 factors compared between the two stocks.

How does Humacyte compare to Alvotech?

Humacyte (NASDAQ:HUMAW) and Alvotech (NASDAQ:ALVOW) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, profitability, risk, valuation, earnings, institutional ownership and dividends.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Humacyte	$2.02M	N/A	N/A	N/A	N/A
Alvotech	$586.32M	N/A	N/A	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
Humacyte	N/A	N/A	N/A
Alvotech	N/A	N/A	N/A

In the previous week, Humacyte's average media sentiment score of 0.00 equaled Alvotech'saverage media sentiment score.

Company	Overall Sentiment
Humacyte	Neutral
Alvotech	Neutral

Summary

Alvotech beats Humacyte on 1 of the 1 factors compared between the two stocks.

How does Humacyte compare to Aravive?

Humacyte (NASDAQ:HUMAW) and Aravive (NASDAQ:ARAV) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, earnings, valuation, media sentiment, profitability and analyst recommendations.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Humacyte	$2.02M	N/A	N/A	N/A	N/A
Aravive	N/A	N/A	N/A	-$0.90	N/A

Company	Net Margins	Return on Equity	Return on Assets
Humacyte	N/A	N/A	N/A
Aravive	N/A	N/A	N/A

In the previous week, Humacyte's average media sentiment score of 0.00 equaled Aravive'saverage media sentiment score.

Company	Overall Sentiment
Humacyte	Neutral
Aravive	Neutral

35.8% of Aravive shares are owned by institutional investors. 60.4% of Aravive shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Aravive beats Humacyte on 2 of the 3 factors compared between the two stocks.

How does Humacyte compare to Atlantic Coastal Acquisition Corp. II?

Humacyte (NASDAQ:HUMAW) and Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) are both pharmaceutical products companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, risk, earnings, profitability, institutional ownership, dividends, analyst recommendations and valuation.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Humacyte	$2.02M	N/A	N/A	N/A	N/A
Atlantic Coastal Acquisition Corp. II	N/A	N/A	N/A	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
Humacyte	N/A	N/A	N/A
Atlantic Coastal Acquisition Corp. II	N/A	N/A	N/A

In the previous week, Humacyte's average media sentiment score of 0.00 equaled Atlantic Coastal Acquisition Corp. II'saverage media sentiment score.

Company	Overall Sentiment
Humacyte	Neutral
Atlantic Coastal Acquisition Corp. II	Neutral

Summary

Humacyte beats Atlantic Coastal Acquisition Corp. II on 1 of the 1 factors compared between the two stocks.

How does Humacyte compare to Biofrontera?

Humacyte (NASDAQ:HUMAW) and Biofrontera (NASDAQ:BFRIW) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, profitability, analyst recommendations, media sentiment, valuation, earnings, risk and dividends.

Company	Net Margins	Return on Equity	Return on Assets
Humacyte	N/A	N/A	N/A
Biofrontera	N/A	N/A	N/A

In the previous week, Humacyte's average media sentiment score of 0.00 equaled Biofrontera'saverage media sentiment score.

Company	Overall Sentiment
Humacyte	Neutral
Biofrontera	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Humacyte	$2.02M	N/A	N/A	N/A	N/A
Biofrontera	$43.20M	N/A	N/A	N/A	N/A

Summary

Biofrontera beats Humacyte on 1 of the 1 factors compared between the two stocks.

Get Humacyte News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HUMAW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HUMAW vs. The Competition

Export

Metric	Humacyte	Biotechnology Industry	Medical Sector	NASDAQ Exchange
Market Cap	N/A	$435.24M	$6.48B	$11.99B
Dividend Yield	N/A	3.86%	2.67%	5.58%
P/E Ratio	N/A	3.20	23.69	23.74
Price / Sales	N/A	6,555.73	514.83	109.27
Price / Cash	N/A	13.13	26.99	37.25
Price / Book	N/A	86.76	10.43	6.78
Net Income	N/A	-$96.07M	$3.57B	$337.51M
7 Day Performance	N/A	-1.43%	0.27%	-2.34%
1 Month Performance	N/A	0.83%	3.25%	1.88%
1 Year Performance	N/A	54.21%	22.24%	25.55%

Humacyte Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HUMAW Humacyte	N/A	$0.05 +1.7%	N/A	-90.9%	$0.00	$2.02M	N/A	150	Gap Down
AIMDW Ainos	N/A	$0.13 -0.3%	N/A	+23.2%	$0.00	$18.11K	N/A	40	News Coverage Positive News Gap Down
ALVOW Alvotech	N/A	$0.26 flat	N/A	-88.1%	$0.00	$586.32M	N/A	4	Positive News Gap Up
ARAV Aravive	N/A	$0.04 flat	N/A	N/A	$0.00	N/A	N/A	20	High Trading Volume
ACABW Atlantic Coastal Acquisition Corp. II	N/A	$0.00 flat	N/A	N/A	$0.00	N/A	N/A	15

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:HUMAW) was last updated on 6/9/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Humacyte (HUMAW) Competitors